Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.


  1. Advanced Patent Search
Publication numberUS3861396 A
Publication typeGrant
Publication dateJan 21, 1975
Filing dateAug 8, 1973
Priority dateAug 8, 1973
Publication numberUS 3861396 A, US 3861396A, US-A-3861396, US3861396 A, US3861396A
InventorsNorman Bruckner, Edward Levine, Vincent L Vaillancourt
Original AssigneeHydro Med Sciences Inc
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Drainage tube
US 3861396 A
Means are provided for eliminating negative pressure problem, e.g. in a closed urinary system comprising a catheter, a downwardly extending tube and a collection bag. The tube has an internal coating of a hydrophilic polymer, preferably a 2-hydroxyethyl methacrylate polymer, or can be made completely of the hydrophilic polymer.
Previous page
Next page
Claims  available in
Description  (OCR text may contain errors)

United States Patent A 191 Jan. 21, 1975 vailla'ncourt et al;

DRAIN AGE'TUBE Inventors: Vincent L. Vaillancourt, Livingston;

Norman Bruckner, East Windsor; Edward Levine, Metuchen, all of,

NJ .1 g

Hydro MedScienceslhc New York, NY. Filed: Aug. 8, 1973 Assignee:

U.S. Cl. 128/350 R, 1.28/3-48, 128/349 R IntrCl A6lm 27/00 Field of Search 128/2 R, 349 R, 350, 275

I References Cited UNITED STATES PATENTS Wichterle et al. 128/2 R 3,566,874 3/1971 Shepherd ..12s/349 3,583,401 6/1971 Vaillancourt ..l28/275 Primary ExaminerAldrich F. Medbery Attorney, Agent, or Firm-Cushman, Darby &

Cushm-an [57] ABSTRACT Means are provided for eliminating negative pressure problem, e.g. in a closed urinary system comprising a catheter, a downwardly extending tube and a collection bag. The tube has an internal coating of a hydrophilic polymer, preferably a 2-hydroxyethyl methacrylate polymer, or can be made completely of the hydrophilic polymer.

9 Claims, 9 Drawing Figures DRAINAGE TUBE This invention is concerned with a method for eliminating negative pressure and negative pressure build-up in the invivo and in-vitro drainage systems, more specifically for use in patients being catheterized and/or using shunts, hydro cephalic valves, etc. One current drainage system consists of a catheter to which is affixed a drainage tube and a collection bag for sampling. This system is normally totally closed, with a bacterial filter vent placed in the bag. A major problem with these systems is build-up of negative pressures in the bladder for example, due to the build-up of the fluids columns in the various cannulae (lumens), e.g. see Vaillancourt US. Pat. No. 3,583,401.

This build-up is due to a combination of: a) closed system which precludes the influence of atmospheric pressures which would break this column, and b) the surface tension of the tubing which acts to hold or retain the fluid in the tube.

Methods currently used to overcome this problem include: large bore drain tubing and the placing of a vent in the catheter connector. The former solution suffers from the limitation that the product is bulky and difficult to work with, whereas the latter has been demonstrated to only work for a very short period of time before the filter element gets clogged due to infestations, and/or hydrostatic pressures. This disclosure is concerned with a novel method which allows for the use of smaller bore tubing, as well as functioning over the life of the drainage system.

Briefly, this invention is concerned with using a hydrophilic tubing having an internal diameter of at least 0.2 inch to prevent capillary action as the connecting member (drainage tube) between the cannulae and collector. It has been found that a hydrophilic tube (having water-wetting properties) will not support a column of fluid even though a vacuum may be applied at one end.

The entire connecting member can be made of a water insoluble hydrophilic polymer or alternatively the hydrophilicity can be imparted to a hydrophobic tubing by coating the inside (lumen) surface of a hydrophobic plastic polymer tube with a hydrophilic polymer. This form of the invention has the advantage over the use of an all hydrophilic polymer of being more economical and also of being able to take advantage of the strength, flexibility and other properties of the hydrophobic plastic.

As the hydrophilic polymer there are preferably employed polymers made from a hydrophilic monomer which are a hydroxy lower alkyl acrylate or methacrylate, or hydroxy lower alkoxy lower alkyl acrylate or methacrylate, e.g., 2-hydroxyethyl acrylate, 2- hydroxyethyl methacrylate, diethylene glycol monoacrylate, diethylene glycol monomethacrylate, 2- hydroxypropyl acrylate, Z-hydroxypropyl methacrylate, 3-hydroxypropyl acrylate, 3-hydropropyl methacrylate and dipropylene glycol monomethacrylate. The preferred monomers are hydroxyalkyl acrylates and methacrylates having 2-3 carbon atoms in the hydroxyalkyl group, most preferably Z-hydroxyethyl methacrylatc as stated above. The polymers employed can be organic solvent soluble, e.g.. alcohol soluble, but are water insoluble. The organic solvent soluble polymers can be prepared, for example. as shown in Shepherd U.S. Pat. No. 3,618,213 e.g., example 36 a, b and c or Chromacek US. Pat. No. 3,575,946. The entire disclosure of the Shepherd and Chromacek patents is hereby incorporated by reference.

The hydroxyalkyl acrylate or methacrylate less pref erably can also be replaced in whole or in part by vinyl pyrrolidone, acrylamide, methacrylamide, N-propyl acrylamide, N-isopropyl methacrylamide. N- methylacrylamide, N-methylmethacrylamide. N- methylol acrylamide and N-methylol methacrylamide. N-2hydroxyethyl acrylamide, N-2-hydroxyethyl methacrylamide. Since these monomers usually form water soluble homopolymers they require the presence ofsufficient cross-linking agent or copolymerization with a sufficient amount of the hydroxyalkyl acrylates and methacrylates or other material to render the copolymers water insoluble. When such monomers are employed they are usually used in an amount of 1-60 percent, preferably l25 percent, of the total monomers by weight.

Other enthylenically unsaturated monomers can be used in conjunction with the above monomers to prepare the hydrophilic polymers. The include neutral monomers such as acrylonitrile, methacrylonitrile, vinyl acetate, alkyl acrylates and methacrylates, alkoxyalkyl acrylates and methacrylates.

Examples of alkyl acrylates and methacrylates include methyl acrylate, ethyl acrylate, butyl acrylate, 2- ethylhexyl acrylate, methyl methacrylate and butyl methacrylates. Examples of suitable alkoxyalkyl acrylates and methacrylates are methoxyethyl acrylate, methoxyethyl methacrylate, ethoxyethyl acrylate, ethoxyethyl methacrylate, propoxyethyl acrylate, butoxyethyl methacrylate, methoxypropyl acrylate, ethoxypropyl methacrylate. These comonomers when used in an amount preferably not higher than 50 percent (and usually between 0.5 and 20 percent) of the monomeric mixture contribute to the mechanical properties of the final gel. They should not be used in an amount to impair the hydrophilic nature of the polymer. Other vinyl monomers bearing ionizable functional groups can be copolymerized with the hydroxyalkyl acrylates or methacrylates. They include acidic type monomers such as acrylic acid, methacrylic acid, maleic acid, fumaric acid, itaconic acid, aconitic acid, cinnamic acid, crotonic acid, carboxylic acid, propiolic acid, citra conic acid, vinyl sulfonic acid, p-vinylbenzenesulfonic acid, partial esters such as mono-2-hydroxyethyl itaconate, mono-2-hydroxypropyl citraconate, mono-2- hydroxyethyl maleate, mono-Z-hydroxypropyl fumarate, monomethyl itaconate, monoethyl itaconate, monomethyl cellosolve itaconate (Methyl Cellosolve is the monoethyl ether of diethylene glycol), monomethyl Cellosolve maleate, mono-2-hydroxyethyl aconitate.

They also include basic type monomers such as aminoethyl methacrylate, dimethyl aminoethyl methacrylate, monomethylaminoethyl methacrylate, tbutylaminoethyl methacrylate, p-aminostyrene, oaminostyrene, 2-amino-4-vinyltoluene. diethylaminoethyl acrylate, dimethylaminoethyl acrylate, tbutylaminoethyl acrylate, piperidinoethyl acrylate, piperidinoethyl methacrylate, morpholinoethyl acrylate, morpholinoethyl methacrylate, 2-vinyl pyridine, 3-vinyl pyridine, 4-vinyl pyridine, 2-ethyl-5-vinyl pyridine, dimethylaminopropyl acrylate, dimethylamino propyl methacrylate, dipropylaminoethyl acrylate. dimethylaminoethyl vinyl ether, dimethylaminoethyl vinyl sulfide, diethylaminoethyl vinyl ether, aminoethyl vinyl ether, 2-pyrrolidinoethyl methacrylate 3- (dimethylaminoethyl)-hydroxypropyl acrylate, 3-

(dimethylaminoethyl)-2-hydroxypropyl methacrylate, 2-aminoethyl acrylate, 2-aminoethyl methacrylate. The alkylaminoethyl acrylates and methacrylates are preferred in this group. In particular cases there can be used multipolymers prepared from a mixture of 3, 4 or more of the above monomers. These monomers are usually used in an amount of 0.1 20 percent, preferably 1 to 15 percent of the total monomers.

To make the final product insoluble in water (if it is not already insoluble therein) and organic solvents, it is eventually cross-linked. This is done by sparingly cross-linking the polymer. Preferably, the cross-linking agent is added in an amount of l to percent most preferably, not over 2.0 percent, and still more preferably between 0.1 and 1 percent, although from 0.05 to percent or even percent of cross-linking agents can be used. Cross-linking renders the otherwise solvent soluble polymers insoluble, although it does not impair the hydrophilic properties.

Typical examples of cross-linking agents include ethylene glycol diacrylate, ethylene glycol dimethacrylate, 1,4-butylene dimethacrylate, diethylene glycol dimethacrylate, propylene glycol dimethacrylate, diethylene glycol dimethacrylate, dipropylene glycol dimethacrylate, diethylene glycol diacrylate, dipropylene glycol diacrylate, divinyl benzene, divinyl toluene, diallyl tartrate, allyl pyruvate, allyl malate, divinyl tartrate, triallyl melamine, N,N'-methylene disacrylamide, diallyl maleate, divinyl ether, diallyl monoethylene glycol citrate, ethylene glycol vinyl allyl citrate, allyl vinyl maleate, diallyl itaconate, ethylene glycol diester of itaconic acid, divinyl sulfone, hexahydro-l 3, S-triacryltriazine, triallyl phosphite, diallyl ether of benzene phosphonic acid, polyester of maleic anhydride with triethylene glycol, diallyl aconitrate, divinyl citraconate, diallyl fumarate, ammonium dichromate. Of course toxic crosslinking agents should not be used in therapeutic applications. Cross-linking can also be accomplished with dichromates, e.g., sodium, potassium and ammonium dichromate.

As catalysts for carrying out the polymerization there is employed a free radical catalyst in the range of 0.05 to 1 percent of the polymerizable hydroxyalkyl ester or the like. The preferred amount of catalyst is 0.1 to 0.2 percent of the monomer. Usually only a portion of the catalyst, e.g. 10-20 percent is added initially to the monomer and the balance is added to the casting syrup after partial polymerization. Typical catalysts include t-butyl peroctoate, benzoyl peroxide, isopropyl percarbonate, methyl ethyl ketone peroxide, cumene hydroperoxide, and dicumyl peroxide. Irradiation, e.g., by ultra violet light or gamma rays, also can be employed to catalyze the polymerization. Polymerization can be done at 20 to 150C., usually 40 to 90C.

The solvent soluble polymers can be applied as internal coatings to tubes made of a hydrophobic polymer, and the solvent evaporated. If a cross-linking agent is present the solvent soluble polymer can then be rendered insoluble, e.g., by heating.

It the entire tube is made of a hydrophilic polymer this can be accomplished conveniently by casting a syrup of cross-linkable partial polymer, e.g., using a casting syrup from 100 parts of 2-hydroxyethyl methacrylate and 0.2 parts of ethylene glycol dimethacrylate in the presence of a catalyst, e.g., t-butyl peroctoate,

such as the casting syrup in Shepherd U.S. Pat. No. 3,618,213, example 12 h and then curing to form a hydrophilic, water insoluble tube.

Alternatively instead of using hydrophilic polymer tubing the hydrophilicity can be obtained by internally coating a hydrophobic plastic cannula such as polytetrafluoroethylene, tetrafluoroethylene-hexafluoropropylene copolomer, polyurethane (either of the polyester or polyether type), polyethylene, polypropylene, ethylene-propylene copolymer, ethylene-propylenenon conjugated polyene terpolymer, natural rubber, butadiene-styrene rubber, butadiene-acrylonitrile rubber, polyethylene terepthalate, polystyrene, polymethyl methacrylate, vinylidene chloride-acrylonitrile copolymer. The preferred hydrophobic tubing is made from a vinyl chloride polymer such as polyvinyl chloride and copolymers of vinyl chloride with vinylidene chloride, chlorostyrene, vinyl esters of carboxylic acids, e.g., vinyl acetate, vinyl propionate, vinyl butyrate and vinyl benzoate, esters of unsaturated acids, e.g., alkyl and alkenyl acrylates such as methyl acrylate, ethyl acrylate, propyl acrylate, butyl acrylate and allyl acrylate as well as the corresponding methacrylates, e.g., methyl methacrylate and butyl methacrylate, vinyl aromatic compounds, e.g., styrene, p-ethyl styrene, divinyl benzene, vinyl naphthalene, a-methyl styrene, p-methyl styrene, dienes such as butadiene and isoprene, unsaturated amides such as acrylamide, methacrylamide and acrylanilide and the esters of a, B-unsaturated carboxylic acids, e.g., the methyl, ethyl, propyl, butyl, amyl, hexyl, heptyl, octyl, allyl, methallyl and phenyl esters of maleic, crotonic, itaconic and fumaric acids and the like. Specific examples of such esters are diethyl maleate, dibutyl maleate and dibutyl fumarate.

The copolymers in which at least 50 percent of the copolymers is made from vinyl chloride are preferably employed in the invention as is polyvinyl chloride.

Typical examples of copolymers include vinyl chloride-vinyl acetate (:5 weight ratio), vinyl chloridevinyl acetate (87:13 weight ratio), vinyl chloride-vinyl acetate-maleic anhydride (86:13:1 weight ratio), vinyl chloride-vinylidene chloride (95:5 weight ratio), vinyl chloride-diethyl fumarate (95:5 weight ratio), vinyl choloride-trichloroethylene (95:5 weight ratio).

The resin employed in the tubing, e.g., polyvinyl chloride, can either be plasticized or unplasticized. As the plasticizer there can be employed conventional materials such as dioctyl phthalate, octyl decyl phthalate, tricresyl phosphate, 2-ethylhexyl diphenyl phosphate, dodecyl dicresyl phosphate, tributyl acetyl citrate, dioctyl sebacate, dibutyl sebacate, etc. The plasticizer is used in conventional amount, e.g., 10 to parts for each 100 parts of the vinyl chloride containing resin.

When a tubing such as polyvinyl chloride is coated with the hydrophilic polymer, this can be accomplished in any convenient fashion. Thus the polyvinyl chloride tubing can be dipped in a casting syrup of the hydrophilic polymer and the polymer cured, e.g., there can be used a casting syrup from 98.5 percent of 2- hydroxyethyl methacrylate and 1.5 percent of ethylene glycol dimethacrylate in the manner shown in Shepherd U.S. Pat. No. 3,556,874 col. 3, lines 5-12 and in example 16. lf it is not desired to coat the outside of the tube, then it can be suitably protected in the dipping process, e.g., with a removable (e.g., prelable) covermg.

Any conventional coating process can be employed such as by spray coating or dip coating. There likewise can be used coextrusion so that the hydrophilic polymer is extruded as an integral inner concentric tubular liner for the polyvinyl chloride or other hydrophobic polymer. Spiral tubing can be prepared from the hydrophilic polymer either as the entire tubing or as an inner liner for polyvinyl chloride, etc., by winding on a mandrel. A film of the hydrophilic polymer can be joined to one of polyvinyl chloride on a mandrel.

The catheter employed can be a conventional catheter. e.g., of the Foley type but preferably is a catheter of the type set forth in Shepherd US. Pat. No. 3,566,874 which has an external coating, an internal coating or both an external and internal coating of hydrophilic polymer, e.g., as set forth in examples l9 and 22 of that patent. The entire disclosure of Shepherd US. Pat. No. 3,566,874 is hereby incorporated by reference.

The catheter can be made of natural rubber, synthetic rubber, e.g., poly cis isoprene, butadiene styrene copolymer, silicon rubber, neoprene, polyvinyl chloride, etc.

The invention will be understood best in connection with the drawings wherein:

FIG. 1 is a plan view showing the overall apparatus of the invention;

FIG. 2 is a fragmentary view partially in section of the drainage tube used in FIG. 1;

FIG. 3 is a view along the line 3--3 of FIG. 1;

FIG. 4 is a plan view of an alternative form of drainage tube;

FIG. 5 is a sectional view taken along the line 55 of FIG. 4;

FIG. 6 is a plan view of another form of drainage tube;

FIG. 7 is a view taken along the line 7-7 of FIG. 6;

FIG. 8 is a view of yet another form of drainage tube; and

FIG. 9 is a view taken along the line 99 of FIG. 8.

Referring more specifically to FIG. 1 of the drawings there is shown a conventional hospital bed 2 with a patient 4, covered by sheet 6. In the bladder of the patient there is inserted a Foley catheter 8. The Foley catheter can be of conventional rubber construction but preferably the rubber has external and internal coatings of a copolymer of 2-hydroxyethyl methacrylate and ethylene glycol dimethacrylate (e.g., 99.8:0.2). The catheter can be connected by a conventional adapter (not shown) to the drainage tube 10 which extends downwardly over the side of the bed and is connected to the drainage bag or receptacle 12. The area of urine hold up is designated at 14.

As shown in FIGS. 2 and 3 the drainage tube 10 is made of polyvinyl chloride 16 and there is provided an overall internal coating 18 of hydrophilic cross-linked Z-hydroxyethyl methacrylate-ethylene glycol dimethacrylate copolymer (99.7203).

As shown in FIGS. 4 and 5 there is provided a drainage tube 20 of polyvinyl chloride having internal strips 22, 24, 26, 28 running throughout its length of hydrophilic polymerized 2-hydroxyethyl methacrylate.

FIGS. 6 and 7 show a drainage tube 30 which is made entirely of a copolymer of 2-hydroxyethyl methacrylate and ethylene glycol dimethacrylate (99.8:0.2).

FIGS. 8 and 9 show a polyvinyl chloride drainage tube 32 having a helical inner liner strip 34 of a 2- hydroxyethyl acrylate-ethylene glycol diacrylate copolymer (99.8:0.2).

It is also possible to employ a tube extruded from a mixture of hydrophobic plastic, e.g., polyvinyl chloride and hydrophilic plastic, e.g., polymerized 2- hydroxyethyl methacrylate.

While the invention has been illustrated by an urinary drainage system, the invention is also useful in draining other human and animal cavities, for example, the thoracic suprapubic and cephalic regions.

What is claimed is:

l. A means for eliminating negative pressure and negative pressure build-up in a drainage tube in a system for the drainage of liquid from a body cavity comprising a tube of said system having an internal diameter of at least 0.2 inch, said means further including a coating extending the length of the tube and on at least a part of the inner peripheral surface of the drainage tube, wherein said coating is comprised, at least in part of a hydrophilic, water-insoluble plastic.

2. The means of claim I wherein the inner surface of the drainage tube is composed of said hydrophilic plas- 3. The system of claim 2 wherein the entire drainage tube is made of said hydrophilic plastic.

4. The means of claim 2 wherein the drainage tube is made of a hydrophobic material and has a lumen and the lumen is coated at least in part by a geometrical arrangement of said hydrophilic plastic.

5. The means of claim 4 wherein the lumen is completely coated by said hydrophilic plastic.

6. The means of claim 4 wherein the hydrophobic material is a vinyl chloride polymer.

7. The means according to claim 6 wherein the lumen is completely coated by said hydrophilic plastic.

8. The means according to claim 7 wherein the hydrophilic plastic is a hydroxy lower alkyl acrylate or a hydroxy lower alkyl methacrylate polymer.

9. The means according to claim 8 wherein the hydrophilic plastic is a 2-hydroxyethyl methacrylate polymer.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US3220960 *Dec 21, 1960Nov 30, 1965Wichterle OttoCross-linked hydrophilic polymers and articles made therefrom
US3566874 *Aug 13, 1968Mar 2, 1971Nat Patent Dev CorpCatheter
US3583401 *Jan 21, 1969Jun 8, 1971Bard Inc C RVented closed drainage system with double lumen tube
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3995628 *Apr 25, 1975Dec 7, 1976Travenol Laboratories, Inc.Catheter insertion device
US4276874 *Nov 15, 1978Jul 7, 1981Datascope Corp.Elongatable balloon catheter
US4306557 *Aug 29, 1978Dec 22, 1981North Daniel AVacuum urological surgical irrigating solution collecting system
US4459318 *Jun 10, 1983Jul 10, 1984American Hospital Supply CorporationMethod for forming a self-lubricating fill tube
US4469483 *Aug 25, 1982Sep 4, 1984Baxter Travenol Laboratories, Inc.Radiopaque catheter
US4484577 *May 12, 1982Nov 27, 1984Key Pharmaceuticals, Inc.Drug delivery method and inhalation device therefor
US4516970 *Sep 13, 1982May 14, 1985Kaufman Jack WMedical device
US4557724 *Aug 12, 1983Dec 10, 1985University Of Utah Research FoundationApparatus and methods for minimizing cellular adhesion on peritoneal injection catheters
US4601286 *Apr 20, 1984Jul 22, 1986Kaufman Jack WArticle for the protection of living tissues
US4668224 *Oct 24, 1983May 26, 1987Warner-Lambert CompanyOxidized cellulose as a medical lubricant
US4755171 *May 29, 1987Jul 5, 1988Tennant Jerald LTubular surgical device
US4773902 *May 16, 1985Sep 27, 1988Deseret Medical, Inc.Oxidized cellulose as a medical lubricant
US4781703 *Oct 17, 1985Nov 1, 1988Menlo Care, Inc.Catheter assembly
US4798597 *Apr 29, 1987Jan 17, 1989Sherwood Medical CoFlexible composite intubation tube
US4861617 *Jul 20, 1987Aug 29, 1989Pall CorporationMethod of reducing the adhesion of bubbles in medical equipment
US4959150 *Sep 26, 1988Sep 25, 1990Pall CorporationFluid treatment system having low affinity for proteinaceous materials
US4994047 *May 6, 1988Feb 19, 1991Menlo Care, Inc.Multi-layer cannula structure
US5000731 *Mar 30, 1989Mar 19, 1991Tai-Ting WongShunting device adopted in the intracranial shunting surgical operation for the treatment of hydrocephalus
US5004461 *Mar 23, 1989Apr 2, 1991Wilson Joseph EMethods for rendering plastics thromboresistant and product
US5135516 *Dec 15, 1989Aug 4, 1992Boston Scientific CorporationLubricious antithrombogenic catheters, guidewires and coatings
US5217026 *Apr 6, 1992Jun 8, 1993Kingston Technologies, Inc.Guidewires with lubricious surface and method of their production
US5356400 *May 6, 1993Oct 18, 1994Temple John ELarge bore drainage apparatus
US5368048 *Apr 19, 1993Nov 29, 1994Stoy; George P.Method of making radio-opaque tipped, sleeved guidewire and product
US5397306 *Nov 23, 1993Mar 14, 1995Terumo Kabushiki KaishaCatheter
US5443907 *Dec 7, 1994Aug 22, 1995Scimed Life Systems, Inc.Coating for medical insertion guides
US5472435 *May 21, 1993Dec 5, 1995Navarre Biomedical, Ltd.Drainage catheter
US5554147 *Feb 1, 1994Sep 10, 1996Caphco, Inc.Compositions and devices for controlled release of active ingredients
US5603991 *Sep 29, 1995Feb 18, 1997Target Therapeutics, Inc.Method for coating catheter lumens
US5607417 *Feb 1, 1995Mar 4, 1997Caphco, Inc.Compositions and devices for controlled release of active ingredients
US5779686 *Sep 3, 1996Jul 14, 1998Olympus Optical Co., Ltd.Disposable medical instrument
US5788687 *Jul 31, 1995Aug 4, 1998Caphco, IncCompositions and devices for controlled release of active ingredients
US5800412 *Oct 10, 1996Sep 1, 1998Sts Biopolymers, Inc.Hydrophilic coatings with hydrating agents
US5967714 *Mar 6, 1998Oct 19, 1999Huels AktiengesellschaftProcess for the preparation of antimicrobial plastics
US6203856Sep 14, 1999Mar 20, 2001Huels AktiengesellschaftProcess for the preparation of antimicrobial plastics
US6306422Aug 3, 1998Oct 23, 2001Caphco, Inc.Compositions and devices for controlled release of active ingredients
US6755824Apr 15, 2002Jun 29, 2004Uab Research FoundationPlatelet inhibitor eluting ablation catheter
US6908443Nov 20, 2001Jun 21, 2005Scimed Life Systems, Inc.Intravascular guide wire and method for manufacture thereof
US7032251Dec 10, 2002Apr 25, 2006Kimberly-Clark Worldwide, Inc.Crosslinking agent for coated elastomeric articles
US7063674Oct 9, 2002Jun 20, 2006Scimed Life Systems, Inc.Intravascular guide wire and method for manufacture thereof
US7214201Dec 17, 2004May 8, 2007Boston Scientific Scimed, Inc.Intravascular guide wire and method for manufacture thereof
US7371257Nov 23, 2004May 13, 2008Boston Scientific Scimed, Inc.Stent lining
US8480227Jul 29, 2011Jul 9, 2013Novartis AgSilicone hydrogel lenses with water-rich surfaces
US8529057Jul 29, 2011Sep 10, 2013Novartis AgSilicone hydrogel lens with a crosslinked hydrophilic coating
US8939577May 22, 2013Jan 27, 2015Novartis AgSilicone hydrogel lenses with water-rich surfaces
US8944592Jul 23, 2013Feb 3, 2015Novartis AgSilicone hydrogel lens with a crosslinked hydrophilic coating
US9005700Oct 10, 2012Apr 14, 2015Novartis AgMethod for making UV-absorbing ophthalmic lenses
US9101418 *Feb 28, 2012Aug 11, 2015Terumo Kabushiki KaishaMedical device and vascularization method
US9239409Dec 16, 2014Jan 19, 2016Novartis AgSilicone hydrogel lens with a crosslinked hydrophilic coating
US9244200Dec 9, 2014Jan 26, 2016Novartis AgSilicone hydrogel lenses with water-rich surfaces
US9411171Dec 14, 2015Aug 9, 2016Novartis AgSilicone hydrogel lenses with water-rich surfaces
US9507173Dec 8, 2015Nov 29, 2016Novartis AgSilicone hydrogel lens with a crosslinked hydrophilic coating
US20040107477 *Dec 10, 2002Jun 10, 2004Kimberly-Clark Worldwide, Inc.Crosslinking agent for coated elastomeric articles
US20050090891 *Nov 23, 2004Apr 28, 2005Sahatjian Ronald A.Stent lining
US20050107720 *Dec 17, 2004May 19, 2005Burmeister Paul H.Intravascular guide wire and method for manufacture thereof
US20050119590 *Dec 17, 2004Jun 2, 2005Burmeister Paul H.Intravascular guide wire and method for manufacture thereof
US20050171496 *Jan 10, 2005Aug 4, 2005Guldfeldt Signe U.Conduit device
US20050177133 *Jul 3, 2003Aug 11, 2005Nielsen Henrik L.External urinary catheter
US20060129066 *Feb 7, 2006Jun 15, 2006Burmeister Paul HIntravascular guide wire and method for manufacture thereof
US20060271019 *Oct 14, 2005Nov 30, 2006The Regents Of The University Of CaliforniaDrainage system
US20090005762 *Jun 26, 2007Jan 1, 2009Vasu NishtalaBioabsorbable Drain Tube
US20090182288 *Jan 5, 2009Jul 16, 2009Spenciner David BFlexible Medical Cannula
US20110238163 *Mar 8, 2011Sep 29, 2011Laboratorios Farmaceuticos Rovi S.A.Multi-layered Device
US20120184944 *Jan 19, 2011Jul 19, 2012Tomes Jennifer ECoiled Tubing for Drain Bag Applications
US20120221009 *Feb 28, 2012Aug 30, 2012Terumo Kabushiki KaishaMedical device and vascularization method
USD737429 *Jun 13, 2012Aug 25, 2015Vijay A. DoraiswamyMedical tube with radio-opaque double helix indicia
CN103550853B *Jul 16, 2008Nov 18, 2015弗罗森斯有限公司用于移除尿的系统和方法
EP0502714A1 *Mar 4, 1992Sep 9, 1992Critikon, Inc.Use of surfactants to improve intravenous catheter flashback
EP0945148A1 *Mar 26, 1998Sep 29, 1999Biomat B.V.Endovascular stents with a polymeric coating
WO1981002982A1 *Apr 22, 1981Oct 29, 1981Key PharmaInhalation spirometric device for administering pulmonary medication
WO2004004611A1 *Jul 3, 2003Jan 15, 2004Coloplast A/SConduit device
WO2004004796A1 *Jul 3, 2003Jan 15, 2004Coloplast A/SExternal urinary catheter
WO2006044621A2 *Oct 14, 2005Apr 27, 2006The Regents Of The University Of CaliforniaImproved drainage system
WO2006044621A3 *Oct 14, 2005May 7, 2009Maurice GarciaImproved drainage system
U.S. Classification604/129, 604/265
International ClassificationA61L29/08, A61F5/441
Cooperative ClassificationA61F5/441, A61L29/085
European ClassificationA61L29/08B, A61F5/441